IRTC · XBRL financial data
iRhythm Holdings financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (IRTC's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 125 | 133* | 132 | 148 | 148 | 164* | 159 | 187 | 193 | 209* | 199 | 224 |
| Cost of revenue | 42 | 45* | 44 | 45 | 46 | 49* | 49 | 54 | 56 | 61* | 58 | 61 |
| Gross profit | 82 | 87* | 88 | 103 | 101 | 115* | 109 | 133 | 137 | 148* | 141 | 163 |
| Research and development | 16 | 15* | 17 | 20 | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 94 | 100* | 109 | 107 | 103 | 100* | 120 | 126 | 124 | 122* | 136 | 132 |
| Total operating expenses | 110 | 127* | 126 | 126 | 152 | 119* | 142 | 152 | 146 | 146* | 158 | 166 |
| Operating income (loss) | (28) | (39)* | (38) | (23) | (50) | (4)* | (33) | (19) | (8) | 2* | (16) | (3) |
| Interest income | 2 | 2* | 3 | 7 | 6 | 6* | 5 | 5 | 6 | 5* | 5 | 5 |
| Interest expense | 1 | 1* | 3 | 3 | 3 | 3* | 3 | 3 | 3 | 3* | 3 | 3 |
| Other income (expense) | (0) | 6* | 3 | 6 | 1 | 0* | 1 | 2 | 1 | 2* | 1 | 1 |
| Income tax expense (benefit) | 0 | 0* | 0 | 0 | 0 | 0* | 1 | (0) | 0 | 0* | 1 | 0 |
| Net income (loss) | (27) | (39)* | (46) | (20) | (46) | (1)* | (31) | (14) | (5) | 6* | (14) | (0) |
| Earnings per share, basic USD per share | (0.89) | (1.26)* | (1.47) | (0.65) | (1.48) | (0.04)* | (0.97) | (0.44) | (0.16) | 0.17* | (0.43) | (0.01) |
| Earnings per share, diluted USD per share | (0.89) | (1.26)* | (1.47) | (0.65) | (1.48) | (0.04)* | (0.97) | (0.44) | (0.16) | 0.17* | (0.43) | (0.01) |
| Weighted average shares, basic millions of shares | 31 | 31* | 31 | 31 | 31 | 31* | 32 | 32 | 32 | 32* | 33 | 33 |
| Weighted average shares, diluted millions of shares | 31 | 31* | 31 | 31 | 31 | 31* | 32 | 32 | 32 | 32* | 33 | 33 |
Balance sheet
CSVFiscal quarters (IRTC's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | 47 | 36 | 520 | 551 | 520 | 420 | 375 | 309 | 256 | 236 | 240 | 247 |
| Marketable securities | 111 | 98 | 49 | 11 | 2 | 116 | 145 | 236 | 310 | 348 | 309 | 345 |
| Accounts receivable | 50 | 61 | 90 | 86 | 77 | 80 | 81 | 82 | 76 | 76 | 81 | 84 |
| Inventory | 14 | 14 | 15 | 15 | 15 | 14 | 14 | 18 | 20 | 22 | 24 | 23 |
| Prepaid and other current assets | 12 | 22 | 14 | 15 | 13 | 16 | 20 | 18 | 19 | 22 | 26 | 58 |
| Total current assets | 234 | 231 | 687 | 678 | 628 | 646 | 636 | 664 | 680 | 703 | 681 | 756 |
| Property and equipment, net | 97 | 104 | 112 | 118 | 122 | 125 | 131 | 140 | 149 | 152 | 157 | 165 |
| Right-of-use asset | 61 | 49 | 48 | 47 | 46 | 48 | 46 | 45 | 43 | 42 | 40 | 39 |
| Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total assets | 440 | 433 | 910 | 919 | 910 | 931 | 926 | 964 | 995 | 1,020 | 1,006 | 1,093 |
| Accounts payable | 7 | 6 | 8 | 13 | 8 | 7 | 12 | 13 | 8 | 2 | 9 | 17 |
| Accrued liabilities | 77 | 83 | 70 | 66 | 74 | 85 | 80 | 100 | 118 | 129 | 102 | 158 |
| Total current liabilities | 102 | 107 | 97 | 98 | 100 | 111 | 111 | 132 | 147 | 152 | 132 | 196 |
| Long-term debt | 35 | 35 | — | — | — | — | — | — | — | — | — | — |
| Lease liability, non-current | 82 | 80 | 78 | 76 | 74 | 75 | 72 | 70 | 68 | 65 | 62 | 59 |
| Total liabilities | 220 | 223 | 819 | 820 | 838 | 841 | 839 | 860 | 873 | 867 | 845 | 907 |
| Accumulated deficit | (607) | (646) | (691) | (711) | (758) | (759) | (790) | (804) | (809) | (803) | (817) | (818) |
| Total stockholders' equity | 220 | 210 | 90 | 99 | 72 | 91 | 87 | 104 | 122 | 153 | 161 | 186 |
| Total liabilities and equity | 440 | 433 | 910 | 919 | 910 | 931 | 926 | 964 | 995 | 1,020 | 1,006 | 1,093 |
| Common shares outstanding (cover page) millions of shares | 31 | 31 | 31 | 31 | 31 | 31 | 32 | 32 | 32 | 32 | 33 | 33 |
Cash flows
CSVFiscal quarters (IRTC's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (27) | (39)* | (46) | (20) | (46) | (1)* | (31) | (14) | (5) | 6* | (14) | (0) |
| Stock-based compensation | 21* | 24* | 21 | 22* | 17* | 16* | 23 | 23* | 21* | 21* | 21 | 20* |
| Depreciation and amortization | 4 | 5* | 5 | 5 | 5 | 5* | 5 | 5 | 5 | 5* | 5 | 5 |
| Net cash from operating activities | 1* | (16)* | (52) | 12* | 24* | 19* | (8) | 28* | 35* | 26* | (26) | 51* |
| Purchases of property and equipment | 9* | 14* | 10 | 8* | 9* | 7* | 9 | 10* | 15* | 12* | 7 | 14* |
| Net cash from investing activities | (15)* | 1* | 40 | 15* | (55)* | (122)* | (38) | (101)* | (89)* | (49)* | 30 | (49)* |
| Share repurchases | 0* | 0* | 25 | 0* | 0* | 0* | 0 | 0* | 0* | 0* | — | — |
| Repayments of long-term debt | 0* | 0* | — | — | — | — | — | — | — | — | — | — |
| Net cash from financing activities | 0* | 3* | 505 | 4* | (0)* | 3* | 2 | 7* | 1* | 3* | 0 | 4* |
| Net change in cash | (14)* | (11)* | 493 | 30* | (31)* | (100)* | (44) | (66)* | (54)* | (20)* | 4 | 7* |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| iRhythm Holdings | 247 | 224 | 51* | 33.0M | 10-QJun 30, 2026 |
| Merit Medical Systems | 504 | 416 | 65* | 59.9M | 10-QSep 30, 2026 |
| TransMedics Group | 491 | 190 | 17* | 34.7M | 10-QJun 30, 2026 |
| Integer Holdings | 14 | 450 | 37* | 34.0M | 10-QOct 2, 2026 |
| GLAUKOS | 162 | 211 | 39* | 59.2M | 10-QSep 30, 2026 |
| Masimo | 125 | 404 | 45 | 52.4M | 10-QApr 4, 2026 |
| Inspire Medical Systems | 191 | 207 | 46* | 29.0M | 10-QSep 30, 2026 |
| MSA Safety | 187 | 536 | 82* | 38.5M | 10-QSep 30, 2026 |
| Globus Medical | 508 | 790 | 210* | 134.3M | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.